Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leach, M. W.
Right arrow Articles by Rennick, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leach, M. W.
Right arrow Articles by Rennick, D. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men"

Michael W. Leach

Schering-Plough Research Institute, Lafayette, New Jersey 07848, michael.leach{at}spcorp.com.

Natalie J. Davidson

DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, California 94304

Madeline M. Fort

DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, California 94304

Fiona Powrie

University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom

Donna M. Rennick

DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, California 94304

Inflammatory bowel disease (IBD) is a generic term typically used to describe a group of idiopathic inflammatory intestinal conditions in humans that are generally divided into Crohn's disease and ulcerative colitis. Although the etiology of these diseases remains unknown, a number of rodent models of IBD have recently been identified, all sharing the concept that the development of chronic intestinal inflammation occurs as a consequence of alterations in the immune system that lead to a failure of normal immunoregulation in the intestine. On the basis of these models, it has been hypothesized that the development of IBD in humans may be related to a dysregulated immune response to normal flora in the gut. Immunodeficient scid mice injected with CD4+ CD45RBhigh T cells and mice deficient in interleukin (IL)-10 (IL-10-/-) are among the rodent models of IBD. In both models, there is inflammation and evidence of a Th1-like response in the large intestine, characterized by CD4+ T-cell and macrophage infiltrates, and elevated levels of interferon-{gamma}. Because IL-10 is an immunomodulatory cytokine that is capable of controlling Thl-like responses, the role of IL-10 was investigated in these models. IL-10 was shown to be important in regulating the development of intestinal inflammation in both models. These results provided key data that supported initiation of clinical trials evaluating the efficacy of IL-10 in patients with IBD.

Key Words: Interleukin-10 • Th1 • colitis • T cell • mucosal immunity

References

  • Abbas AK, Murphy KM, and Sher A. (1996). Functional diversity of helper T lymphocytes. Nature 383: 787-793.[CrossRef][Medline] [Order article via Infotrieve]
  • Aranda R., Sydora BC, McAllister PL, Binder SW, Yang HY, Targan SR, and Kronenberg M. (1997). Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J. Immunol. 158: 3464-3473.[Abstract]
  • Autenrieth IB, Bucheler N., Bohn E., Heinze G., and Horak I. (1997). Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41: 793-800.[Abstract/Free Full Text]
  • Beagley KW, Fujihashi K., Lagoo AS, Lagoo-Deenadaylan S., Black CA, Murray AM, Sharmanov AT, Yamamoto M., McGhee JR, Elson CO and Kiyono H. (1995). Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J. Immunol. 154: 5611-5619.[Abstract]
  • Berg DJ, Davidson N., Kiihn R., Müller W., Menon S., Holland G., Thompson-Snipes L., Leach MW, and Rennick D. (1996). Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses. J. Clin. Invest. 98: 1010-1020.[Web of Science][Medline] [Order article via Infotrieve]
  • Bonhagen K., Thoma S., Leithäuser F., Möller P., and Reimann J. (1998). A pancolitis resembling human ulcerative colitis (UC) is induced by CD4+ TCR {alpha}β T cells of athymic origin in histocompatible severe combined immunodeficient (SCID) mice. Clin. Exp. Immunol. 112: 443-452.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Brandwein SL, McCabe RP, Cong Y., Waites KB, Ridwan BU, Dean PA, Ohkusa T., Birkenmeier EH, Sundberg JP, and Elson CO (1997). Spontaneously colitis C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol. 159: 44-52.[Abstract]
  • Breese E., Braegger CP, Corrigan CJ, Walker-Smith JA, and MacDonald TT (1993). Interleukin-2- and interferon-{gamma}-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78: 127-131.[Web of Science][Medline] [Order article via Infotrieve]
  • Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P., Walker-Smith JA, and MacDonald TT (1994). Tumor necrosis factor {alpha}-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106: 1455-1466.[Web of Science][Medline] [Order article via Infotrieve]
  • Bregenholt S. and Claesson MH (1998). Increased intracellular Th1 cytokines in SCID mice with inflammatory bowel disease. Eur. J. Immunol. 28: 379-389.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bregenholt S., Delbro D., and Claesson MH (1997). T-cell transfer and cytokine/TCR gene deletion models in the study of inflammatory bowel disease. APMIS 105: 655-662.[Web of Science][Medline] [Order article via Infotrieve]
  • Cahill RJ, Foltz CJ, Fox JG, Dangler CA, Powrie F., and Schauer DB (1997). Inflammatory bowel disease: An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect. Immun. 65: 3126-3131.[Abstract]
  • Calkins BM and Mendeloff AI (1995). The epidemiology of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 31-67.
  • Camerini V., Panwala C., and Kronenberg M. (1993). Regional specialization of the mucosal immune system. J. Immunol. 151: 1765-1776.[Abstract]
  • Cao X., Shores EW, Hu-Li J., Anver MR, Kelsall BL, Russell SM, Drago J., Noguchi M., Grinberg A., Bloom ET, Paul WE, Katz SI, Love PE, and Leonard WJ (1995). Defective lymphoid development in mice lacking expression of the common cytokine receptor {gamma} chain. Immunity 2: 223-238.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Casini-Raggi V., Kam L., Chong Yjt, Fiocchi C., Pizarro TT, and Cominelli F. (1995). Mucosal imbalance in IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. J. Immunol. 154: 2434-2440.[Abstract]
  • Chernoff AE, Granowitz EV, Shapiro L., Vanneir E., Lonnemann G., Angel JB, Kennedy JS, Rabson AR, Wolff SM, and Dinarello CA (1995). A randomized, controlled trial of IL-10 in humans. J. Immunol. 154: 5492-5499.[Abstract]
  • Claesson MH, Rudolphi A., Kofoed S., Poulsen SS, and Reimann J. (1996). CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin. Exp. Immunol. 104: 491-500.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cong Y., Brandwein SL. McCabe RP, Lazenby A., Birkenmeier EH, Sundberg JP, and Elson CO (1998). CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med. 187: 855-864.[Abstract/Free Full Text]
  • Davidson NJ, Fort MM, Müller W., Leach MW, and Rennick DM (1998). Chronic colitis in IL-10-/- mice: Insufficient counter regulation of a Th1 response. Int. Rev. Immunol. (in press).
  • Davidson NJ, Hudak SA, Lesley RE, Menon S., Leach MW, and Rennick DM (1998). IL-12, but not interferon-{gamma}, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161: 3143-3149.[Abstract/Free Full Text]
  • Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L., Kühn R., Miiller W., Berg DJ, and Rennick DM (1996). T helper cell 1 type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184: 241-251.[Abstract/Free Full Text]
  • de Vries JE (1995). Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann. Med. 27: 537-541.[Web of Science][Medline] [Order article via Infotrieve]
  • Dianda L., Hanby AM, Wright NA, Sebsteny A., Hayday AC, and Owen MJ (1997). T cell receptor-{alpha}β-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150: 91-97.[Abstract]
  • Dionne S., D'Agata D., Hiscott J., Vanounou T., and Seidman EG (1998). Colonic explant production of IL-1 and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 112: 435-442.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Duchmann R., Kaiser I., Hermann E., Mayet W., Ewe K., and Meyer zum Büschenfelde KH ( 1995). Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 448-455.[Web of Science][Medline] [Order article via Infotrieve]
  • Duchmann R., Schmitt E., Knolle P., Meyer zum Büschenfelde KH, and Neurath M. (1998). Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol. 26: 934-938.[CrossRef]
  • Ehrhardt RO, Ludviksson BR, Gray B., Neurath M., and Strober W. (1997). Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158: 566-573.[Abstract]
  • Elson CO (1996). The basis of current and future therapy for inflammatory bowel disease. Am. J. Med. 100: 656-662.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Elson CO, Sartor RB, Tennyson GS, and Riddell RH (1995). Experimental models of inflammatory bowel disease. Gastroenterology 109: 1344-1367.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fort MM, Leach MW, and Rennick DM (1998). A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J. Immunol. 161: 3256-3261.[Abstract/Free Full Text]
  • Fox JG (1997). The expanding genus of Helicobacter: Pathogenic and zoonotic potential. Semin. Gastrointest. Dis. 8: 124-141.
  • Fox JG, Yan L., Shames B., Campbell J., Murphy JC, and Li X. (1996). Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect. Immun. 64: 3673-3681.[Abstract]
  • Funakoshi K., Sugimura K., Sasakawa T., Bannai H., Anezaki K., Ishizuka K., Yoshida K., Narisawa R., and Asakura H. (1995). Study of cytokines in ulcerative colitis. J. Gastroenterol. 30: 61-63.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fuss IJ, Neurath M., Boirivant M., Klein JS, de la Motte C., Strong SA, Fiocchi C., and Strober W. (1996). Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J. Immunol. 157: 1261-1270.[Abstract]
  • Gaskins HR, Vondrak-Juergens GL, McCracken BA, and Woolsey JH (1997). Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/ HeJBir mice. Lab. Anim. Sci. 47: 650-655.
  • Geissler K. (1996). Current status of clinical development of interleukin-10. Curr. Opin. Hematol. 3: 203-208.[Medline] [Order article via Infotrieve]
  • Gross V., Andus T., Caesar I., Roth M., and Schölmerich J. (1992). Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 102: 514-519.[Web of Science][Medline] [Order article via Infotrieve]
  • Groux H., Bigler M., de Vries JE, and Roncarolo MG (1996). Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184: 19-29.[Abstract/Free Full Text]
  • Groux H., O'Garra A., Bigler M., Rouleau M., Antonenki S., de Vries JE, and Roncarolo MG (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.[CrossRef][Medline] [Order article via Infotrieve]
  • Hagenbaugh A., Sharma S., Dubinett SM, Wei Shy, Aranda R., Cheroutre H., Fowell DJ, Binder S., Tsao B., Locksley RM, Moore KW, and Kronenberg M. (1997). Altered immune responses in interleukin 10 transgenic mice. J. Exp. Med. 185: 2101-2110.[Abstract/Free Full Text]
  • Haines DC, Gorelick PL, Battles JK, Pike KM, Anderson RJ, Fox JG, Taylor NS, Shen Z., Dewhirst FE, Anver MR, and Ward JM (1998). Inflammatory large bowel disease in immunodeficient rats naturally and experimentally infected with Helicobacter bilis. Vet. Pathol. 35: 202-208.[Abstract]
  • Hammer RE, Maika SD, Richardson JA, Tang JP, and Taurog JD (1990). Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: An animal model of HLA-B27-associated human disorders. Cell 63: 1099-1112.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hara J., Ohtani H., Matsumoto T., Nakamura S., Kitano A., Arakawa T., Nagura H., and Kobayashi K. (1997). Expression of costimulatory molecules B7-1 and B7-2 in macrophages and granulomas of Crohn's disease: Demonstration of cell-to-cell contact with T lymphocytes. Lab. Invest. 77: 175-184.[Web of Science][Medline] [Order article via Infotrieve]
  • Harper PH, Lee Ecg, Kettlewell Mgw, Bennett MK, and Jewell DP (1985). Role of the faecal stream in the maintenance of Crohn's colitis. Gut 26: 279-284.[Abstract/Free Full Text]
  • Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S., and Sartor RB (1996). Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 39: 836-845.[Abstract/Free Full Text]
  • Hermiston ML and Gordon JI (1995). Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270: 1203-1207.[Abstract/Free Full Text]
  • Hollander D. (1993). Permeability in Crohn's disease: Altered barrier functions in healthy relatives? Gastroenterology 104: 1848-1851.[Web of Science][Medline] [Order article via Infotrieve]
  • Holländer GA, Simpson SJ, Mizoguchi E., Nichoglannopoulou A., She J., Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B., and Terhorst C. (1995). Severe colitis in mice with aberrant thymic selection. Immunity 3: 27-38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hörnquist CE, Lu X., Rogers-Fani PM, Rudolph U., Shappell S., Birnbaumer L., and Harriman GR (1997). G{alpha}i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J. Immunol. 158: 1068-1077.[Abstract]
  • Ito H. and Fathman CG (1997). CD45RBhigh CD4+ T cells from INF-{gamma} knockout mice do not induce wasting disease. J. Autoimmun. 10: 455-459.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Krämer S., Schimpl A., and Hünig TR (1995). Immunopathology of interleukin (IL) 2-deficient mice: Thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene. J. Exp. Med. 182: 1769-1776.[Abstract/Free Full Text]
  • Kucharzik T., Lügering N., Adolf M., Domschke W., and Stoll R. (1997). Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig. Dis. Sci. 42: 805-812.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kucharzik T., Lügering N., Pauels HG, Domschke W., and Stoll R. (1998). IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin. Exp. Immunol. 111: 152-157.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kucharzik T., Lügering N., Weigelt H., Adolf M., Domschke W., and Stoll R. (1996). Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin. Exp. Immunol. 104: 483-490.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kucharzik T., Stoll R., Lügering N., and Domschke W. (1995). Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin. Exp. Immunol. 100: 452-456.[Web of Science][Medline] [Order article via Infotrieve]
  • Kühn R., Löhler J., Rennick D., Rajewsky K., and Müller W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kulkarni AB, Ward JM, Yaswen L., Mackall CL, Bauer SR, Huh CG, Gress RE, and Karlsson S. (1995). Transforming growth factor-β1 null mice. An animal model for inflammatory disorders. Am. J. Pathol. 146: 264-275.[Abstract]
  • Lalani I., Bhol K., and Ahmed AR (1997). Interleukin-10: Biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79: 469-483.[Web of Science][Medline] [Order article via Infotrieve]
  • Lapidus A., Bernell O. Hellers G. and Löfberg R. (1998). Clinical course of colorectal Crohn's disease: A 35-year follow-up study of 507 patients. Gastroenterology 114: 1151-1160.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lasher BA (1995). Clinical features, laboratory findings, and course of Crohn's disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 344-354.
  • Leach MW, Bean Agd, Mauze S., Coffman RL, and Powrie F. (1996). Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells. Am. J. Pathol. 148: 1503-1515.[Abstract]
  • Lewin KJ, Riddell RH, and Weinstein WM (1992). Inflammatory bowel diseases. In: Gastrointestinal Pathology and Its Clinical Implications, KJ Lewin, RH Riddell, and WM Weinstein (eds). Igaku-Shoin, New York, pp. 812-989.
  • Lúdvíksson BR, Ehrhardt RO, and Strober W. (1997). TGF-β production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J. Immunol. 159: 3622-3628.[Abstract]
  • Lúdvíksson BR, Gray B., Strober W., and Ehrhardt RO (1997). Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes. J. Immunol. 158: 104-111.[Abstract]
  • Lügering N., Kucharzik T., Stein H., Winde G., Lügering A., Hasilik A., Domschke W., and Stoll R. (1998). IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease. Dig. Dis. Sci. 43: 706-714.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • MacDermott RP (1996). Alterations of the mucosal immune system in inflammatory bowel disease. J. Gastroenterol. 31: 907-916.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • MacDonald TT (1995). Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102: 445-447.[Web of Science][Medline] [Order article via Infotrieve]
  • May GR, Sutherland LR, and Meddings JB (1993). Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 104: 1627-1632.[Web of Science][Medline] [Order article via Infotrieve]
  • McDonald Sac, Palmen Mjhj, van Rees EP, and MacDonald TT (1997). Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology 91: 73-80.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Merger M. and Croitoru K. (1998). Infections in the immunopathogenesis of chronic inflammatory bowel disease. Semin. Immunol. 10: 69-78.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mitsuyama K., Sasaki E., Toyonaga A., Ikeda H., Tsuruta O., Irie A., Arima N., Oriishi T., Harada K., Fujisaki K., Sata M., and Tanikawa K. (1991). Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 50: 104-111.[Web of Science][Medline] [Order article via Infotrieve]
  • Mizoguchi A., Mizoguchi E., Chiba M., and Bhan AK (1996). Role of appendix in the development of inflammatory bowel disease in TCR-{alpha} mutant mice. J. Exp. Med. 184: 707-715.[Abstract/Free Full Text]
  • Mizoguchi A., Mizoguchi E., Chiba M., Spiekermann GM, Tonegawa S., Nagler-Andeson C., and Bhan AK ( 1996). Cytokine imbalance and autoantibody production in T cell receptor-{alpha} mutant mice with inflammatory bowel disease. J. Exp. Med. 183: 847-856.[Abstract/Free Full Text]
  • Mizoguchi A., Mizoguchi E., Smith RN, Preffer FI, and Bhan AK (1997). Suppressive role of B cells in chronic colitis of T cell receptor {alpha} mutant mice. J. Exp. Med. 186: 1749-1756.[Abstract/Free Full Text]
  • Mizoguchi E., Mizoguchi A., and Bhan AK (1997). Role of cytokines in the early stages of chronic colitis in TCR{alpha}-mutant mice. Lab. Invest. 76: 385-397.[Web of Science][Medline] [Order article via Infotrieve]
  • Mombaerts P., Mizoguchi E., Grusby MJ, Glimcher LH, Bhan AK, and Tonegawa S. (1993). Spontaneous development in inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 275-282.[CrossRef][Web of Science]
  • Monteleone G., Biancone L., Marasco R., Morrone G. Marasco O, Luzza F., and Pallone F. (1997). Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112: 1169-1178.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Morrissey PJ and Charrier K. (1994). Induction of wasting disease in SCID mice by the transfer of normal CD4+/CD45RBhi T cells and the regulation of this autoreactivity by CD4+/CD45RB- T cells. Res. Immunol. 145: 357-362.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Morrissey PJ, Charrier K., Braddy S., Liggitt D., and Watson JD (1993). CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by co-transfer of purified CD4+ T cells. J. Exp. Med. 178: 237-244.[Abstract/Free Full Text]
  • Mosmann TR, Cherwinski H., Bond MW, Giedlon MA, and Coffman RL (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.[Abstract]
  • Moss AA, Carbone JV, and Kressel HY (1978). Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. Am. J. Roentgenol. 131: 787-790.[Abstract]
  • Murata Y., Ishiguro Y., Itoh J., Munakata A., and Yoshida Y. (1995). The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J. Gastroenterol. 30: 56-60.[Web of Science][Medline] [Order article via Infotrieve]
  • Murch SH, Braegger CP, Walker-Smith JA, and MacDonald TT (1993). Location of tumour necrosis factor {alpha} by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705-1709.[Abstract/Free Full Text]
  • Narula SK, Cutler D., and Grint P. (1998). Immunomodulation of Crohn's disease by interleukin-10. Agents Actions Suppl. 49: 57-65.[Medline] [Order article via Infotrieve]
  • Neurath MF, Fuss I., Kelsall B., Presky DH, Waegell W., and Strober W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183: 2605-2616.[Abstract/Free Full Text]
  • Niessner M. and Volk BA (1995). Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101: 428-435.[Web of Science][Medline] [Order article via Infotrieve]
  • Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., Maggi E., Pupilli C., Tonelli F., and Romagnani S. (1997). Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 150: 823-832.[Abstract]
  • Powrie F. (1995). T cells in inflammatory bowel disease: Protective and pathogenic roles. Immunity 3: 171-174.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Powrie F., Carlino J., Leach MW, Mauze S., and Coffman RL (1996). A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J. Exp. Med. 183: 2669-2674.[Abstract/Free Full Text]
  • Powrie F., Leach MW, Mauze S., Caddle LB, and Coffman RL (1993). Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5: 1461-1471.[Abstract/Free Full Text]
  • Powrie F., Leach MW, Mauze S., Menon S., Caddle LB, and Coffman RL (1994). Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Powrie F., Mauze S., and Coffman RL (1997). CD4+ T-cells in the regulation of inflammatory responses in the intestine. Res. Immunol. 148: 576-581.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Prantera C., Zannoni F., Spimpolo N., and Bonfa M. (1994). Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: Results of an open study. J. Clin. Gastroenterol. 19: 79-80.[Web of Science][Medline] [Order article via Infotrieve]
  • Rath H., Herfarth HH. Ikeda JS, Grenther WB, Hamm TE Jr, Balish E., Taurog JD, Hammer RE, Wilson KH, and Sartor RB (1996). Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J. Clin. Invest. 98: 945-953.[Web of Science][Medline] [Order article via Infotrieve]
  • Reif S., Klein I., Lubin F., Farbstein M., Hallak A., and Gilat T. (1997). Pre-illness dietary factors in inflammatory bowel disease. Gut 40: 754-760.[Abstract/Free Full Text]
  • Reimann J., Rudolphi A., SpieB S., and Claesson MH (1995). A gut-homing, oligoclonal CD4+ T cell population in severe-combined immunodeficient mice expressing a rearranged, transgenic class I-restricted {alpha}β T cell receptor. Eur. J. Immunol. 25: 1643-1653.[Web of Science][Medline] [Order article via Infotrieve]
  • Reinecker HC, Steffen M., Witthoeft T., Pflueger I., Schreiber S., MacDermott RP, and Raedler A. (1993). Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94: 174-181.[Web of Science][Medline] [Order article via Infotrieve]
  • Retsky JL and Kraft SC (1995). The extraintestinal manifestations of inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 474-491.
  • Riddell RH (1995). Pathology of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 517-552.
  • Robinson M. (1997). Optimizing therapy for inflammatory bowel disease. Am. J. Gastroenterol. 92: 12S-17S.[Medline] [Order article via Infotrieve]
  • Rogler G. and Andus T. (1998). Cytokines in inflammatory bowel disease. World J. Surg. 22: 382-389.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rudolph U., Finegold MJ, Rich SS, Harriman GR, Srinivasan Y., Brabet P., Boulay G., Bradley A., and Birnbaumer L. (1995). Ulcerative colitis and adenocarcinoma of the colon in G{alpha}12-deficient mice. Nat. Genet. 10: 143-149.[Web of Science][Medline] [Order article via Infotrieve]
  • Rudolphi A., Boll G., Poulsen SS, Claesson MH, and Reimann J. (1994). Gut-homing CD4+ T cell receptor {alpha}β+ T cells in the pathogenesis of murine inflammatory bowel disease. Eur. J. Immunol. 24: 2803-2812.[Web of Science][Medline] [Order article via Infotrieve]
  • Rudolphi A., Bonhagen K., and Reimann J. (1996). Polyclonal expansion of adoptively transferred CD4+ {alpha}β T cells in the colonic lamina propria of SCID mice with colitis. Eur. J. Immunol. 26: 1156-1163.[Web of Science][Medline] [Order article via Infotrieve]
  • Rugtveit J., Brandtzaeg P., Halstensen TS, Fausa O., and Scott H. (1994). Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes. Gut 35: 669-674.[Abstract/Free Full Text]
  • Rugtveit J., Nilsen EM, Bakka A., Carlsen H., Brandzaeg P., and Scott H. (1997). Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112: 1493-1505.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rutgeerts P., Goboes K., Peeters M., Hiele M., Penninckx F., Aerts R., Kerremans R., and Vantrappen G. (1991). Effect of faecal stream diversion in recurrence of Crohn's disease in the neoterminal ileum. Lancet 338: 771-774.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rutgeerts P., Hiele M., Geboes K., Peeters M., Penninckx F., Aerts R., and Kerremans R. (1995). Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1817-1821.
  • Sadlack B., Merz H., Schorle H., Schimpl A., Feller AC, and Horak I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253-261.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sartor RB (1990). Role of intestinal microflora in initiation and perpetuation of inflammatory bowel disease. Can. J. Gastroenterol. 4: 271-277.
  • Sartor RB (1995). Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis, and experimental intestinal inflammation. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 96-124.
  • Scholmerich J. (1997). Immunosuppressive treatment for refractory ulcerative colitis—Where do we stand and where are we going? Eur. J. Gastroenterol. Hepatol. 9: 842-849.[Web of Science][Medline] [Order article via Infotrieve]
  • Schreiber S., Heinig T., Panzer U., Reinking R., Bouchard A., Stahl PD, and Raedler A. (1995). Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108: 21-33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schreiber S., Heinig T., Thiele HG, and Raedler A. (1995). Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 108: 1434-1444.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schreiber S., Raedler A., Stenson WF, and MacDermott RP (1992). The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol. Clin. North Am. 21: 451-502.
  • Shomer NH, Dangler CA, Schrenzel MD, and Fox JG (1997). Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect. Immun. 65: 4858-4864.[Abstract]
  • Shorter RG, Huizenga KA, and Spencer RJ (1972). A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Dig. Dis. 17: 1024-1032.[CrossRef]
  • Simpson SJ, Holländer GA, Mizoguchi E., Allen D., Bhan AK, Wang B., and Terhorst C. (1997). Expression of pro-inflammatory cytokines by TCR{alpha}β+ and TCR{gamma}{delta}+ T cells in an experimental model of colitis. Eur. J. Immunol. 27: 17-25.[Web of Science][Medline] [Order article via Infotrieve]
  • Simpson SJ, Mizoguchi E., Allen D., Bhan AK, and Terhorst C. (1995). Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol. 25: 2618-2625.[Web of Science][Medline] [Order article via Infotrieve]
  • Simpson SJ, Shah S., Comiskey M., de Jong YP, Wang B., Mizoguchi E., Bhan AK, and Terhorst C. (1998). T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon {gamma} expression by T cells. J. Exp. Med. 187: 1225-1234.[Abstract/Free Full Text]
  • Singleton JW (1995). Clinical features, course, and laboratory findings in ulcerative colitis. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 335-343.
  • Strober W., Kelsall B., Fuss I., Marth T., Ludviksson B., Ehrhardt R., and Neurath M. (1997). Reciprocal INF-{gamma} and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today 18: 61-64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sundberg JP, Elson CO, Bedigian H., and Birkenmeier EH (1994). Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 107: 1726-1735.[Web of Science][Medline] [Order article via Infotrieve]
  • Takahashi I., Kiyono H., and Hamada S. (1997). CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor {alpha} chain-deficient mice. Gastroenterology 112: 1876-1886.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tanaka M. and Riddell RH (1990). The pathological diagnosis and differential diagnosis of Crohn's disease. Hepato-Gastroenterology 37: 18-31.
  • Thomas ML (1989). The leukocyte common antigen family. Annu. Rev. Immunol. 7: 339-369.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tomoyose M. Mitsuyama K, Ishida H., Toyonaga A., and Tanikawa K. (1998). Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand. J. Gastroenterol. 33: 435-440.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tremaine WJ (1997). Refractory IBD: Medical management. Neth. J. Med. 50: S12-S14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • van Deventer SJ, Elson CO, and Fedorak RN (1997). Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Gastroenterology 113: 383-389.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wagner N., Löhler J., Kunkel EJ, Ley K., Leung E., Krissansen G., Rajewsky K., and Müller W. (1996). Critical role for β7 intergrins in formation of the gut-associated lymphoid tissue. Nature 382: 366-370.[CrossRef][Medline] [Order article via Infotrieve]
  • Ward JM, Anver MR, Haines DC, Melhorn JM, Gorelick PL, Yan L., and Fox JG ( 1996). Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab. Anim. Sci. 46: 15-20.
  • Watanabe M., Ueno Y., Yajima T., Okamoto S., Hayashi T., Yamazaki M., Iwao Y., Ishii H., Habu S., Uehira M., Nishimoto H., Ishikawa H., Hata JI, and Hibi T. (1998). Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187: 389-402.[Abstract/Free Full Text]
  • Willerford DM, Chen J., Ferry JA, Davidson L., Ma A., and Alt FW (1995). Interleukin-2 receptor {alpha} chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521-530.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wyatt J., Vogelsang H., Hiibl W., Waldhöer T., and Lochs H. (1993). Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341: 1437-1439.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yang H. and Rotter JI (1995). Genetic aspects of idiopathic inflammatory bowel disease. In: Inflammatory Bowel Disease, JB Kirsner and RG Shorter (eds). Williams & Wilkins, Baltimore, Maryland, pp. 301-331.
  • Youngman KR, Simon PL, West GA, Cominelli F., Rachmilewitz D., Klein JS, and Fiocchi C. (1993). Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104: 749-758.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 27, No. 1, 123-133 (1999)
DOI: 10.1177/019262339902700124
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S.-H. Lo and T. Zheng
A demonstration and findings of a statistical approach through reanalysis of inflammatory bowel disease data
PNAS, July 13, 2004; 101(28): 10386 - 10391.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M Waidmann, Y Allemand, J Lehmann, S di Genaro, N Bucheler, A Hamann, and I B Autenrieth
Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-{gamma} and TNF-{alpha} production
Gut, February 1, 2002; 50(2): 170 - 179.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
F. S. Laroux, K. P. Pavlick, R. E. Wolf, and M. B. Grisham
Dysregulation of Intestinal Mucosal Immunity: Implications in Inflammatory Bowel Disease
Physiology, December 1, 2001; 16(6): 272 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Kawachi, S. Jennings, J. Panes, A. Cockrell, F. S. Laroux, L. Gray, M. Perry, H. van der Heyde, E. Balish, D. N. Granger, et al.
Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G734 - G743.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leach, M. W.
Right arrow Articles by Rennick, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leach, M. W.
Right arrow Articles by Rennick, D. M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?